Denka opens first overseas research and development facility in Singapore

SINGAPORE - Japanese specialty chemical firm Denka Company has opened its new research and development (R&D)facility in Singapore - its first outside of Japan.

The Denka Life Innovation Research Centre Singapore, opened in a closed-door ceremony on Feb 13, is a US$2 million (S$2.8 million) life sciences research institute.

It will be manned by 10 researchers, including those from the Agency for Science, Technology and Research (A*Star) and Biopolis community.

The facility will work on vaccines, diagnostic reagents as well as anti-cancer drugs, genetic testing and health check-ups.

"At present, we are strengthening our businesses in the region related to the health and life sciences field where sustained growth is expected," said Denka in a statement.

"With the opening of the (new) facility, we have ramped up efforts to promote open innovation. We have been accelerating R&D projects, including proprietary seasonal influenza vaccines ... to easily diagnose Zika fever, Dengue fever and other tropical infectious diseases."

The new facility introduces a new function to Denka's portfolio in Singapore, which further anchors Singapore as its home base in South-east Asia. Denka has four manufacturing plants here, along with two headquarters and a technical services centre.

Dr Beh Swan Gin, chairman of the Singapore Economic Development Board, said: "The establishment of Denka's life sciences R&D laboratory here reflects Singapore's attractiveness for companies seeking to develop products that address diseases prevalent in the region.

"With functions ranging from manufacturing, regional headquarters and now, to R&D, Denka is a good example of how companies can orchestrate their growth in Asia through Singapore, and in the process, create good jobs for Singaporeans."

Join ST's Telegram channel and get the latest breaking news delivered to you.